|
The department of Insulin and Incretin Biology consists of scientists, research technicians and students. We are dedicated to initiate and drive research projects to improve future insulin and incretin therapies.
Our prime aim is to be innovative and challenge current ways of thinking insulin and incretin biology and analogues design. The ultimate goal is to feed the early research pipeline with innovative projects; the first step in the discovery of improved insulin and incretin analogues for improved diabetes treatment.
Our focus in future design of insulin and incretin analogues is to obtain an increased understanding of insulin and GLP-1 receptor signalling as well as the functional outcome of receptor activation by these ligands in various tissues.
|
To develop new insulins and GLP-1 analogues with novel add-on benefits
